Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | cannabinoid receptor 1 (brain) | Starlite/ChEMBL | References |
Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Starlite/ChEMBL | No references |
Rattus norvegicus | Cannabinoid CB1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Onchocerca volvulus | 4'-phosphopantetheinyl transferase ffp | 224 aa | 186 aa | 26.3 % | |
Trichomonas vaginalis | conserved hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 197 aa | 22.3 % |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Entamoeba histolytica | hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 198 aa | 28.3 % |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0372 | 0.4114 | 1 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.01 | 0.0788 | 0.0788 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.3061 | 0.5 |
Onchocerca volvulus | 0.01 | 0.0788 | 0.2574 | |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0456 | 0.5 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0188 | 0.1855 | 0.4509 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0456 | 0.0456 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0388 | 0.4308 | 0.4308 |
Onchocerca volvulus | 0.0286 | 0.3061 | 1 | |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0456 | 1 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.01 | 0.0788 | 0.2989 |
Schistosoma mansoni | serine-rich repeat protein | 0.02 | 0.2011 | 0.4889 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.2011 | 0.4889 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.01 | 0.0788 | 0.0788 |
Brugia malayi | Cache domain containing protein | 0.0172 | 0.1661 | 0.6302 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.01 | 0.0788 | 0.1915 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0853 | 1 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0456 | 0.5 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0456 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0388 | 0.4308 | 0.4308 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0456 | 0.0456 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0456 | 0.1109 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0788 | 0.2989 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.1661 | 0.6302 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2636 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0456 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0456 | 0.5 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2636 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0456 | 0.1109 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 912 nM | Displacement of [3H]-CP55940 from human CB1 receptor by liquid scintillation counting in presence of serine protease inhibitor PMSF | ChEMBL. | 23865723 |
Ki (binding) | = 1.4 uM | Binding affinity for cannabinoid receptor 2 | ChEMBL. | 16078824 |
Ki (binding) | = 1.9 uM | Binding affinity for cannabinoid receptor 1 | ChEMBL. | 16078824 |
Ki (binding) | = 1.9 uM | Binding affinity for cannabinoid receptor 1 | ChEMBL. | 16078824 |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (binding) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | = 63.0957 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 70.7946 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.